Factors Predicting Discordant Virological and Immunological Responses to Antiretroviral Therapy in HIV-1 Clade C Infected Zulu/Xhosa in South Africa

• Boris Julg ,

  Contributed equally to this work with: Boris Julg, Danielle Poole, Musie Ghebremichael

  * E-mail: bjulg@partners.org

  Affiliations Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America, HIV Pathogenesis Programme, Doris Duke Medical Research Institute and KwaZulu Natal Research Institute for TB and HIV, University of KwaZulu Natal, Durban, South Africa

  ⨯
• Danielle Poole ,

  Contributed equally to this work with: Boris Julg, Danielle Poole, Musie Ghebremichael

  Affiliations Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America, HIV Pathogenesis Programme, Doris Duke Medical Research Institute and KwaZulu Natal Research Institute for TB and HIV, University of KwaZulu Natal, Durban, South Africa

  ⨯
• Musie Ghebremichael ,

  Contributed equally to this work with: Boris Julg, Danielle Poole, Musie Ghebremichael

  Affiliations Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America, Department of Biostatistics and Computational Biology, Harvard University and Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Carmen Castilla,

  Affiliation University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States of America

  ⨯
• Marcus Altfeld,

  Affiliations Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America, HIV Pathogenesis Programme, Doris Duke Medical Research Institute and KwaZulu Natal Research Institute for TB and HIV, University of KwaZulu Natal, Durban, South Africa

  ⨯
• Henry Sunpath,

  Affiliation McCord Hospital, Durban, South Africa

  ⨯
• Richard A. Murphy,

  Affiliation Operational Support Unit, Doctors Without Borders, New York, New York, United States of America

  ⨯
• Bruce D. Walker

  Affiliations Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America, HIV Pathogenesis Programme, Doris Duke Medical Research Institute and KwaZulu Natal Research Institute for TB and HIV, University of KwaZulu Natal, Durban, South Africa, Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America

  ⨯